Hospital tests cheaper copy of popular arthritis drug
NCT ID NCT02998398
Summary
This study looked at whether patients could safely switch from the brand-name drug Remicade to a very similar, lower-cost version called Inflectra. It involved 262 patients at a Paris hospital who were already using Remicade for conditions like rheumatoid arthritis or Crohn's disease. Researchers tracked if patients stayed on the new drug and if their disease remained under control after the switch.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Cochin
Paris, Paris, 75014, France
Conditions
Explore the condition pages connected to this study.